Related Experiment Video

Updated: Jul 6, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Preoperative statin intake and morbid events after isolated coronary artery bypass grafting

Kathirvel Subramaniam1, Colleen Gorman Koch, Allen Bashour

  • 1Department of Anesthesiology, UPMC Presbyterian Hospital, Pittsburgh, PA, USA. subramaniamk@upmc.edu

Journal of Clinical Anesthesia
|March 19, 2008
PubMed

Insights

Preoperative statin use did not significantly impact major morbid events or mortality in patients undergoing coronary artery bypass grafting (CABG). This study found no benefit in reducing perioperative complications for patients taking statins before surgery.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Research

Background:

  • Statins are widely used for cardiovascular disease prevention.
  • Their role in mitigating perioperative complications after coronary artery bypass grafting (CABG) requires further investigation.

Purpose of the Study:

  • To evaluate the impact of preoperative statin therapy on morbidity and mortality in patients undergoing isolated CABG.

Main Methods:

  • Observational cohort study of 2497 adult patients undergoing isolated CABG.
  • Propensity score matching was used to compare outcomes between statin and non-statin users.
  • Key endpoints included major morbid events and in-hospital mortality.

Main Results:

  • Propensity matching created comparable groups (654 pairs).
  • No significant difference in perioperative mortality (0.76% vs 1.2%, P=0.40) was observed.
  • Cardiac, neurologic, renal, respiratory morbidity, atrial fibrillation, and hospital stay were similar between groups.

Conclusions:

  • Preoperative statin administration did not demonstrate a reduction in major perioperative morbid events following isolated CABG.
  • Further research may be needed to clarify the role of statins in this patient population.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...